# MACBIS50 in Patients Undergoing CAG During Normothermic CPB Phase.

> **NCT02711384** · — · COMPLETED · sponsor: **Instituto Dante Pazzanese de Cardiologia** · enrollment: 15 (actual)

## Conditions studied

- Coronary Disease
- Coronary Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02711384
- **Lead sponsor:** Instituto Dante Pazzanese de Cardiologia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-25
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-02-28
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02711384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02711384, "MACBIS50 in Patients Undergoing CAG During Normothermic CPB Phase.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02711384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*